JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB131272

Anti-ACTL6A antibody [EPR7443]

Be the first to review this product! Submit a review

|

(8 Publications)

Rabbit Recombinant Monoclonal ACL6A antibody. Suitable for IHC-P, WB and reacts with Human, Mouse, Rat samples. Cited in 8 publications.

View Alternative Names

BAF53, BAF53A, INO80K, ACTL6A, Actin-like protein 6A, 53 kDa BRG1-associated factor A, Actin-related protein Baf53a, ArpNbeta, BRG1-associated factor 53A, INO80 complex subunit K

3 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACTL6A antibody [EPR7443] (AB131272)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACTL6A antibody [EPR7443] (AB131272)

Immunohistochemical analysis of paraffin embedded Human colon tissue labelling ACTL6A with ab131272 at 1/50 dilution.

Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACTL6A antibody [EPR7443] (AB131272)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACTL6A antibody [EPR7443] (AB131272)

Immunohistochemical analysis of paraffin embedded Human breast carcinoma tissue labelling ACTL6A with ab131272 at 1/50 dilution.

Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Western blot - Anti-ACTL6A antibody [EPR7443] (AB131272)
  • WB

Unknown

Western blot - Anti-ACTL6A antibody [EPR7443] (AB131272)

All lanes:

Western blot - Anti-ACTL6A antibody [EPR7443] (ab131272) at 1/1000 dilution

Lane 1:

Ramos cell lysate at 10 µg

Lane 2:

K562 cell lysate at 10 µg

Lane 3:

HeLa cell lysate at 10 µg

Lane 4:

Jurkat cell lysate at 10 µg

Secondary

All lanes:

HRP labelled Goat anti-Rabbit IgG at 1/2000 dilution

Predicted band size: 47 kDa

false

  • Carrier free

    Anti-ACTL6A antibody [EPR7443] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR7443

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

The immunogen used for this product shares 79% homology with ACTL6B. Cross-reactivity with this protein has not been confirmed experimentally.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50 - 1/100", "IHCP-species-notes": "<p>(Heat to 98°C, allow to cool for 10-20 minutes)</p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>" }, "Rat": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ACTL6A also known as BAF53A or Arp4 is a member of the actin-related protein family with a molecular mass of approximately 53 kDa. This protein plays an important role in chromatin remodeling facilitating transcriptional regulation by altering nucleosome positioning. ACTL6A shows expression in various tissues with high levels found in neurons and certain cancer cell types. Its function depends on local cellular context which influences its involvement in specific gene expression profiles.
Biological function summary

ACTL6A supports transcriptional regulation by integrating into the SWI/SNF chromatin-remodeling complex. This complex which includes other key proteins coordinates to reposition nucleosomes aiding transcription factors in accessing target DNA sequences. ACTL6A contributes to regulation of gene expression patterns that underline cell identity and differentiation reflecting its critical role in neuronal and cancer cell biology.

Pathways

The SWI/SNF complex which includes ACTL6A integrates into pathways that control cell proliferation and differentiation. Specifically the Wnt signaling pathway uses ACTL6A to regulate gene expression necessary for proper cell function. Proteins like BRG1 and BRM serve as partners in this process helping to execute transcriptional activation. By participating in these pathways ACTL6A emphasizes its role in conserving cellular homeostasis.

ACTL6A exhibits associations with oncogenesis and neural disorders. Researchers observed its link to the development of glioblastoma where it influences tumor progression through interactions with other SWI/SNF members like SMARCA4. Additionally abnormalities in ACTL6A function relate to neurodevelopmental disorders emphasizing its importance in neuronal growth and differentiation. Its connection to these diseases highlights the potential of ACTL6A as a target for therapeutic interventions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Required for maximal ATPase activity of SMARCA4/BRG1/BAF190A and for association of the SMARCA4/BRG1/BAF190A containing remodeling complex BAF with chromatin/nuclear matrix. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and is required for the proliferation of neural progenitors. During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). Component of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage. Putative core component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair.
See full target information ACTL6A

Publications (8)

Recent publications for all applications. Explore the full list and refine your search

Cancer 130:1435-1448 PubMed38358781

2024

Discovery of a proliferation essential gene signature and actin-like 6A as potential biomarkers for predicting prognosis and neoadjuvant chemotherapy response in triple-positive breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaofen Li,Shiping Luo,Wenfen Fu,Mingyao Huang,Xiewei Huang,Shaohong Kang,Jie Zhang,Qingshui Wang,Chuangui Song

Frontiers in oncology 11:724832 PubMed34395295

2021

Potential Role of SWI/SNF Complex Subunit Actin-Like Protein 6A in Cervical Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Qingying Wang,Zuozeng Cao,Yingze Wei,Jiawen Zhang,Zhongping Cheng

Cell death & disease 10:811 PubMed31649264

2019

ACTL6A regulates follicle-stimulating hormone-driven glycolysis in ovarian cancer cells via PGK1.

Applications

Unspecified application

Species

Unspecified reactive species

Jiawen Zhang,Jing Zhang,Yingze Wei,Qingxian Li,Qingying Wang

Nucleic acids research 47:9619-9636 PubMed31392992

2019

EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex.

Applications

Unspecified application

Species

Unspecified reactive species

Saravana P Selvanathan,Garrett T Graham,Alexander R Grego,Tabari M Baker,J Robert Hogg,Mark Simpson,Mona Batish,Brian Crompton,Kimberly Stegmaier,Eleni M Tomazou,Heinrich Kovar,Aykut Üren,Jeffrey A Toretsky

Cell death & disease 9:517 PubMed29725063

2018

Actin like-6A promotes glioma progression through stabilization of transcriptional regulators YAP/TAZ.

Applications

Unspecified application

Species

Unspecified reactive species

Jianxiong Ji,Ran Xu,Xin Zhang,Mingzhi Han,Yangyang Xu,Yuzhen Wei,Kaikai Ding,Shuai Wang, Bin Huang,Anjing Chen, Di Zhang,Zheng Jiang,Shuo Xu,Qing Zhang,Wenjie Li,Shilei Ni,Jian Wang,Xingang Li

The Journal of biological chemistry 293:3892-3903 PubMed29374058

2018

Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.

Applications

Unspecified application

Species

Unspecified reactive species

Aktan Alpsoy,Emily C Dykhuizen

Genes & development 29:1298-315 PubMed26080815

2015

Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells.

Applications

Unspecified application

Species

Human

Neil T Pfister,Vitalay Fomin,Kausik Regunath,Jeffrey Y Zhou,Wen Zhou,Laxmi Silwal-Pandit,William A Freed-Pastor,Oleg Laptenko,Suat Peng Neo,Jill Bargonetti,Mainul Hoque,Bin Tian,Jayantha Gunaratne,Olav Engebraaten,James L Manley,Anne-Lise Børresen-Dale,Paul M Neilsen,Carol Prives

eLife 4: PubMed25803486

2015

Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells.

Applications

WB

Species

Human

Patrick Laurette,Thomas Strub,Dana Koludrovic,Céline Keime,Stéphanie Le Gras,Hannah Seberg,Eric Van Otterloo,Hana Imrichova,Robert Siddaway,Stein Aerts,Robert A Cornell,Gabrielle Mengus,Irwin Davidson
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com